Table 6: Treatment of chronic infection. |
||
Agent |
Nebulized |
Oral or intravenous |
Pseudomonas |
Tobramycin (solution for nebulization): 300 mg/5 mL twice daily 28 days of treatment followed by 28 days of rest in e-Flow®, Pari LC plus® Gentamicin (inhaled intravenous formulation): 80 mg twice daily continuous treatment |
If despite nebulized treatment poor clinical control persists, associate an oral or intravenous antibiotic with activity according to antibiogram, on demand or in cycles |
MRS |
Vancomycin (intravenous formulation administered by nebulized route): 250 mg/2 times a day continuous treatment |
If the response is insufficient or there is intolerance, add or replace vancomycin with IV linezolid |
Other germs |
Gentamicin: 80 mg/2 times daily or any of those used for pseudomone continuous treatment |
If the response is insufficient or there is intolerance, consider adding (or replacing) the nebulized antibiotic with an oral one according to sensitivity |
MRS = Methicillin-resistant Staphylococcus aureus. |